ATRenew
RERE · NYSE
About RERE
- Employees
- 2,389
- Headquarters
- Shanghai, Shanghai
- Listed
- Jun 18, 2021
- Sector
- Consumer Discretionary
- Industry
- Specialty Retail
- Website
- ir.atrenew.com
RERE key statistics
- Market cap
- 827.55M
- Price-earnings ratio
- 8.53
- Dividend yield
- —
- Average volume
- 447.83K
- Volume
- 345.53K
- Open price
- $3.76
- High today
- $3.89
- Low today
- $3.76
- 52 Week high
- $6.47
- 52 Week low
- $3.50
ATRenew (RERE) at a glance
As of Oct 23, 2026, ATRenew (RERE) shares are priced at $3.84, giving the company a market cap of 827.55M and a price-to-earnings ratio of 8.53.
Today the stock has traded between $3.76 and $3.89. The current price is 2.1% above the day's low and 1.3% below its high.
Volume so far is 345.53K shares, below the average of 447.83K shares a day.
Over the past year ATRenew has ranged from $3.50 to $6.47, and now sits 11% of the way up that range.
ATRenew met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY26 it reported $0.65 per share against an estimate of $0.9078.
The average analyst price target is $6.72, 75.0% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $5.55
- Now
- $3.84
- High
- $8.40
RERE earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 1 of the last 8 quarters, by 712.3% on average.
- Q2 FY24: reported $0.32 per share against an estimate of $0.51
- Q3 FY24: reported $0.37 per share against an estimate of $0.561
- Q1 FY25: reported $0.48 per share against an estimate of $0.612
- Q2 FY25: reported $0.41 per share against an estimate of $0.5814
- Q3 FY25: reported $0.45 per share against an estimate of $0.612
- Q4 FY25: reported $0.5498 per share against an estimate of $0.8262
- Q1 FY26: reported $0.58 per share against an estimate of $0.0714
- Q2 FY26: reported $0.65 per share against an estimate of $0.9078
RERE news
- Press releasePRNewswire
- Press releasePRNewswire
ATRenew to Report Second Quarter 2026 Financial Results on August 20, 2026
- Press releasePRNewswire
ATRenew Unveils Upgraded Overseas Strategy and Opens Its First ReRe Store in Hong Kong
- Press releasePRNewswire
ATRenew Releases 2025 ESG Report: Advancing Sustainable Growth by Leading the Circular Economy
12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session
- Opeyemi Babalola
What Inno Holdings Stock Surge Reveals About Micro-Cap AI Speculation
- Bamboo Works
ATRenew Posts Record Q1 Profit, Fastest Revenue Growth In 3 Years
- Priya Nigam
ATRenew Reports Strong Q1 Results As Direct Retail, Trade-In Volumes Surge
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.